Insider Trading (Form 4)
NASDAQ
Gilead Raday, Chief Operating Officer of RedHill Biopharma Ltd., sold 14,130,000 shares of common stock on July 10, 2026 for $0.00 per share.
NASDAQ
Chief Operating Officer Gilead Raday sold 15,740,000 ordinary shares to satisfy tax obligations related to RSU vesting.
Schedule 13G - Passive Investments
NASDAQ
YA II PN, Ltd. and its affiliates disclosed a 9.9% beneficial ownership stake in RedHill Biopharma Ltd. following a Standby Equity Distribution Agreement.
Capital raise
NASDAQ
Alumni Capital LP, its general partner, and manager have jointly filed a Schedule 13G, disclosing beneficial ownership of 9.99% of RedHill Biopharma Ltd.'s American Depository Shares.
Capital raise